Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130.
- DOI
- 10.3390/ijms27104293
- Published
- 2026 May 12
- Container
- International journal of molecular sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27104293,
title = {Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130.},
author = {Navone SE and Guarnaccia L and Rizzaro MD and Begani L and Barilla E and Alotta G and Garzia E and Caroli M and Ampollini A and Violetti A and Gervasi N and Campanella R and Riboni L and Locatelli M and Marfia G},
year = {2026},
journal = {International journal of molecular sciences},
doi = {10.3390/ijms27104293},
url = {https://doi.org/10.3390/ijms27104293}
}RIS
TY - JOUR TI - Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130. AU - Navone SE AU - Guarnaccia L AU - Rizzaro MD AU - Begani L AU - Barilla E AU - Alotta G AU - Garzia E AU - Caroli M AU - Ampollini A AU - Violetti A AU - Gervasi N AU - Campanella R AU - Riboni L AU - Locatelli M AU - Marfia G PY - 2026 JO - International journal of molecular sciences DO - 10.3390/ijms27104293 UR - https://doi.org/10.3390/ijms27104293 ER -
APA
SE, N., L, G., MD, R., L, B., E, B., G, A., E, G., M, C., A, A., A, V., N, G., R, C., L, R., M, L., & G, M. (2026). Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130.. International journal of molecular sciences. https://doi.org/10.3390/ijms27104293
Source records
- pubmed · retrieved 2026-09-26T00:07:12.123Z